The only Japanese company*1 to obtain approval for the use of Bifidobacteria in Brazil Three Bifidobacterium strains, BB536, M-16V, and M-63, approved for use by Brazil’s “ANVISA”*1
Approval also given for stating on the label the health benefits of digestive and intestinal care.

Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea

Morinaga Milk’s Bifidobacterium breve MCC1274 wins Ingredient of the Year at NutraIngredients-Asia Awards 2023
in the category of Cognitive Function

Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil

Intake of LAC-Shield™ maintains good physical condition of healthy adult men and women Confirmed the effectiveness of LAC-Shield™ selected to “support health”
- Published in the scientific journal Nutrients-

Morinaga Milk Unveils New Research of Bifidobacterium longum subsp. infantis M-63 Improving the Intestinal Environment in Healthy Term Infants

Received the Award for Science and Technology (Development Category) of the 2023 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology

Morinaga Milk Obtains FDA GRAS Notification for its Probiotic
Bifidobacterium infantis M-63 for use in Infant Formula and General Foods

Morinaga Milk uncovers clue about infant gut microbiome assembly

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods

Morinaga Milk's Probiotic Bifidobacterium longum BB536 Wins 2020 NutraIngredients-Asia Award for 'Editors' Award for the Infant & Child Nutrition of the Year'

New Evidence Shows Morinaga Milk's Probiotic Bifidobacterium breve MCC1274 Improves Memory of Older Adults With Cognitive Dysfunction

Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium longum BB536 in Infant Formula